Aarkstore - Visceral Pain - Pipeline Review, H2 2014 - PowerPoint PPT Presentation

About This Presentation
Title:

Aarkstore - Visceral Pain - Pipeline Review, H2 2014

Description:

This report provides comprehensive information on the therapeutic development for Vaginal Atrophy (Atrophic Vaginitis), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. Browse full report @ – PowerPoint PPT presentation

Number of Views:19

less

Transcript and Presenter's Notes

Title: Aarkstore - Visceral Pain - Pipeline Review, H2 2014


1
Visceral Pain - Pipeline Review, H2 2014
Healthcare Market Research Report
2
Summary
  • Visceral Pain - Pipeline Review, H2 2014,
    provides an overview of the Visceral Pains
    therapeutic pipeline.
  • This report provides comprehensive information
    on the therapeutic development for Visceral Pain,
    complete with comparative analysis at various
    stages, therapeutics assessment by drug target,
    mechanism of action (MoA), route of
    administration (RoA) and molecule type, along
    with latest updates, and featured news and press
    releases. It also reviews key players involved in
    the therapeutic development for Visceral Pain and
    special features on late-stage and discontinued
    projects.
  • Global Markets Directs report features
    investigational drugs from across globe covering
    over 20 therapy areas and nearly 3,000
    indications. The report is built using data and
    information sourced from Global Markets Directs
    proprietary databases, Company/University
    websites, SEC filings, investor presentations and
    featured press releases from company/university
    sites and industry-specific third party sources,
    put together by Global Markets Directs team. Drug
    profiles/records featured in the report undergoes
    periodic updation following a stringent set of
    processes that ensures that all the profiles are
    updated with the latest set of information. 

3
Scope
  • - The report provides a snapshot of the global
    therapeutic landscape of Visceral Pain- The
    report reviews key pipeline products under drug
    profile section which includes, product
    description, MoA and RD brief, licensing and
    collaboration details other developmental
    activities - The report reviews key players
    involved in the therapeutics development for
    Visceral Pain and enlists all their major and
    minor projects- The report summarizes all the
    dormant and discontinued pipeline projects - A
    review of the Visceral Pain products under
    development by companies and universities/research
    institutes based on information derived from
    company and industry-specific sources- Pipeline
    products coverage based on various stages of
    development ranging from pre-registration till
    discovery and undisclosed stages
  • Browse full report or Sample Request _at_
  • http//www.aarkstore.com/pharmaceuticals-healthcar
    e/100598/visceral-pain-pipeline-review-h2-2014

4
Reasons to buy
  • - Provides strategically significant competitor
    information, analysis, and insights to formulate
    effective RD development strategies- Identify
    emerging players with potentially strong product
    portfolio and create effective counter-strategies
    to gain competitive advantage- Develop strategic
    initiatives by understanding the focus areas of
    leading companies- Identify and understand
    important and diverse types of therapeutics under
    development for Visceral Pain- Plan mergers and
    acquisitions effectively by identifying key
    players of the most promising pipeline- Devise
    corrective measures for pipeline projects by
    understanding Visceral Pain pipeline depth and
    focus of Indication therapeutics- Develop and
    design in-licensing and out-licensing strategies
    by identifying prospective partners with the most
    attractive projects to enhance and expand
    business potential and Scope- Modify the
    therapeutic portfolio by identifying discontinued
    projects and understanding the factors that drove
    them from pipeline

5
Table of Content
  • IntroductionREPORT COVERAGEVisceral Pain
    OverviewTherapeutics DevelopmentPipeline
    Products for Visceral Pain - OverviewPipeline
    Products for Visceral Pain - Comparative
    AnalysisVisceral Pain - Therapeutics under
    Development by CompaniesVisceral Pain - Pipeline
    Products GlanceClinical Stage ProductsEarly
    Stage ProductsVisceral Pain - Products under
    Development by CompaniesVisceral Pain -
    Companies Involved in Therapeutics
    DevelopmentNektar TherapeuticsAstellas Pharma
    Inc.Neurim Pharmaceuticals LtdGrunenthal GmbH

6
List of Tables
  • Number of Products under Development for Visceral
    Pain, H2 2014Number of Products under
    Development for Visceral Pain - Comparative
    Analysis, H2 2014Number of Products under
    Development by Companies, H2 2014Comparative
    Analysis by Clinical Stage Development, H2
    2014Comparative Analysis by Early Stage
    Development, H2 2014Products under Development
    by Companies, H2 2014Visceral Pain - Pipeline by
    Nektar Therapeutics, H2 2014Visceral Pain -
    Pipeline by Astellas Pharma Inc., H2
    2014Visceral Pain - Pipeline by Neurim
    Pharmaceuticals Ltd, H2 2014Visceral Pain -
    Pipeline by Grunenthal GmbH, H2 2014Visceral
    Pain - Pipeline by Trevena, Inc., H2
    2014Visceral Pain - Pipeline by Hydra
    Biosciences, Inc., H2 2014Visceral Pain -
    Pipeline by GIcare Pharma Inc, H2 2014Visceral
    Pain - Pipeline by Istituto Italiano di
    Tecnologia, H2 2014

7
List of Figures
  • Number of Products under Development for Visceral
    Pain, H2 2014Number of Products under
    Development for Visceral Pain - Comparative
    Analysis, H2 2014Number of Products under
    Development by Companies, H2 2014Assessment by
    Monotherapy Products, H2 2014Number of Products
    by Top 10 Target, H2 2014Number of Products by
    Stage and Top 10 Target, H2 2014Number of
    Products by Top 10 Mechanism of Action, H2
    2014Number of Products by Stage and Top 10
    Mechanism of Action, H2 2014Number of Products
    by Stage and Top 10 Route of Administration, H2
    2014Number of Products by Stage and Top 10
    Molecule Type, H2 2014

8
Related Reports
  • Intrauterine Contraceptive Devices Market
    (IUD/IUCD),by Type Hormonal IUCD, Copper IUCD
    Global Forecast to 2019
  • Asian Healthcare Workflow Systems Market by Type
    (Fraud Detection, Pharmacy Audit Analysis,
    Claim Management System, Customer Relationship
    Management), by End-User - Forecast to 2019
  • Healthcare IT (HIT) Market in the APAC Region
    2015-2019
  • Complete 2015-16 Induced Pluripotent Stem Cell
    (iPSC) Industry Report
  • Global Healthcare BPO Market 2015-2019
  • Colposcopy Test, Market, Users Forecast - Asia
    Middle East Analysis
  • Point of Care Diagnostic Testing World Markets
  • Europe Laboratory Information System Market

9
Follow Us
https//www.facebook.com/aarkstoredotcom
https//twitter.com/aarkstore
https//plus.google.com/Aarkstoredotcom/posts
https//www.linkedin.com/company/aarkstore-enterpr
ise
10
Contact Us
Office Address Office No. - 809, 8th
Floor,B-Wing, Mahaavir Icon, Plot No.- 89 90,
Sector-15,CBD-Belapur, Navi Mumbai
400614, Maharashtra, India. Mail us at
contact_at_aarkstore.com 24/7 Online Support 91
9987295242 General Inquiries 91 - 22 2756 4953
Write a Comment
User Comments (0)
About PowerShow.com